Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1698077 |
394 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//SHIKONIN | 32432 |
4054 | 2 | ORAL TUMOR CELLS//DENT PHARMACOL//DIAGNOST THER EUT SCI | 743 |
22287 | 1 | ORAL TUMOR CELLS//DENT PHARMACOL//DIAGNOST THER EUT SCI | 410 |
28313 | 1 | L HISTIDINOL//ZILASCORBH 2//SPARSOMYCIN | 228 |
35933 | 1 | AK 5 TUMOR//AK 5 TUMOUR CELLS//ANTIBODY DAUNOMYCIN CONJUGATE | 105 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ORAL TUMOR CELLS | authKW | 652559 | 3% | 77% | 20 |
2 | DENT PHARMACOL | address | 636941 | 14% | 14% | 105 |
3 | DIAGNOST THER EUT SCI | address | 509141 | 7% | 25% | 49 |
4 | L HISTIDINOL | authKW | 342157 | 1% | 73% | 11 |
5 | SASA SENANENSIS REHDER | authKW | 296919 | 1% | 100% | 7 |
6 | BENZYLIDENE ASCORBATE | authKW | 259802 | 1% | 88% | 7 |
7 | TYPE OF CELL DEATH | authKW | 259802 | 1% | 88% | 7 |
8 | HUMAN ORAL TUMOR CELLS | authKW | 254502 | 1% | 100% | 6 |
9 | MEIKAI PHARMACO MED | address | 254502 | 1% | 100% | 6 |
10 | ANALYT CHEM MED | address | 247174 | 2% | 45% | 13 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 5903 | 46% | 0% | 345 |
2 | Medicine, Research & Experimental | 560 | 11% | 0% | 84 |
3 | Chemistry, Medicinal | 308 | 7% | 0% | 50 |
4 | Pharmacology & Pharmacy | 252 | 13% | 0% | 97 |
5 | Cell Biology | 119 | 8% | 0% | 63 |
6 | CYTOLOGY & HISTOLOGY | 83 | 1% | 0% | 4 |
7 | Immunology | 53 | 6% | 0% | 44 |
8 | Biophysics | 25 | 3% | 0% | 24 |
9 | Integrative & Complementary Medicine | 21 | 1% | 0% | 6 |
10 | Biochemistry & Molecular Biology | 16 | 9% | 0% | 66 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DENT PHARMACOL | 636941 | 14% | 14% | 105 |
2 | DIAGNOST THER EUT SCI | 509141 | 7% | 25% | 49 |
3 | MEIKAI PHARMACO MED | 254502 | 1% | 100% | 6 |
4 | ANALYT CHEM MED | 247174 | 2% | 45% | 13 |
5 | MED BIOCHEM 1 SHINAGAWA KU | 218143 | 1% | 86% | 6 |
6 | MPL | 217153 | 2% | 32% | 16 |
7 | TECHNICIANS SECT | 212085 | 1% | 100% | 5 |
8 | MEIKAI PHARMACOMED | 193899 | 1% | 57% | 8 |
9 | ORAL BIOL TISSUE ENGN | 142030 | 2% | 28% | 12 |
10 | MEIKAI PHARMACOMED MPL | 135733 | 1% | 80% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTICANCER RESEARCH | 94797 | 28% | 1% | 208 |
2 | IN VIVO | 69438 | 9% | 2% | 66 |
3 | CYTOKINES CELLULAR & MOLECULAR THERAPY | 5465 | 1% | 3% | 4 |
4 | SBORNIK LEKARSKY | 2801 | 0% | 2% | 3 |
5 | CHEMICAL & PHARMACEUTICAL BULLETIN | 1152 | 3% | 0% | 22 |
6 | NATURAL IMMUNITY AND CELL GROWTH REGULATION | 1084 | 0% | 1% | 2 |
7 | INVESTIGATIONAL NEW DRUGS | 1033 | 1% | 0% | 8 |
8 | POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY | 867 | 1% | 1% | 4 |
9 | ANTI-CANCER DRUGS | 798 | 1% | 0% | 8 |
10 | CYTOKINES AND MOLECULAR THERAPY | 784 | 0% | 2% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |